Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julia Cave Arbanas"'
Autor:
Chi-Hong Tseng, Arpan Patel, John N Mafi, Folasade P May, Catherine Sarkisian, Courtney A Reynolds, Vishnu Nair, Chad Villaflores, Katherine Dominguez, Julia Cave Arbanas, Madeline Treasure, Samuel Skootsky, Kevin Ghassemi, A Mark Fendrick
Publikováno v:
BMJ Open Quality, Vol 12, Iss 4 (2023)
Objectives Low-value esophagogastroduodenoscopies (EGDs) for uncomplicated gastro-oesophageal reflux disease (GERD) can harm patients and raise patient and payer costs. We developed an electronic health record (EHR) ‘eMeasure’ to detect low-value
Externí odkaz:
https://doaj.org/article/af6d968c08de4aae90ad16e8319c9e72
Autor:
John N Mafi, Anne M Walling, Chad Villaflores, Sitaram Vangala, Andrea Sorensen, Eric Cheng, Ashley Turner, Zoe Trutner, Grace Cheng, Julia Cave Arbanas, Benjamin Waterman, Suzanne Shu, Noah Goldstein, Catherine Sarkisian
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0277409 (2022)
Among patients with Alzheimer's disease and its related dementias (ADRD) with behavioral disturbances, antipsychotic prescriptions have limited efficacy and increase the risk of death. Yet, physicians continue to routinely prescribe low-value antipsy
Externí odkaz:
https://doaj.org/article/667fc9781ca24127884bf9dcbef33675
Autor:
Carlos Irwin A. Oronce, Julia Cave Arbanas, Mei Leng, Bruce E. Landon, Cheryl L. Damberg, Catherine Sarkisian, John N. Mafi
Publikováno v:
Journal of the American Geriatrics Society. 70(9)
Autor:
John N. Mafi, Anne M. Walling, Chad Villaflores, Sitaram Vangala, Andrea Sorensen, Eric Cheng, Ashley Turner, Zoe Trutner, Grace Cheng, Julia Cave Arbanas, Benjamin Waterman, Suzanne Shu, Noah Goldstein, Catherine Sarkisian
Publikováno v:
PloS one. 17(12)
Among patients with Alzheimer’s disease and its related dementias (ADRD) with behavioral disturbances, antipsychotic prescriptions have limited efficacy and increase the risk of death. Yet, physicians continue to routinely prescribe low-value antip
Autor:
John N. Mafi, Mei Leng, Julia Cave Arbanas, Chi-Hong Tseng, Cheryl L. Damberg, Catherine Sarkisian, Bruce E. Landon
Publikováno v:
JAMA health forum. 3(1)
This cross-sectional study examines upper bound and lower bound annualized Medicare costs for administering aducanumab to beneficiaries with the approved indications of mild cognitive impairment or mild dementia.